Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Dabigatran etexilate/rivaroxaban

Intracranial haemorrhage and variceal bleeding

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zhou H, et al. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis. BMC Gastroenterology 23: Sep 2023. Available from: URL: https://dx.doi.org/10.1186/s12876-023-02960-8 Zhou H, et al. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis. BMC Gastroenterology 23: Sep 2023. Available from: URL: https://dx.doi.org/10.1186/s12876-023-02960-8
Metadaten
Titel
Dabigatran etexilate/rivaroxaban
Intracranial haemorrhage and variceal bleeding
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49086-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Remdesivir

Case report

Sorafenib

Case report

Alendronic-acid

Case report

Phenytoin